Vir Biotechnology Total Liabilities

Vir Biotechnology (VIR) currently reports a total liabilities of $230M as of June 2026. That compares with $250M in the prior-year period — down 5.2% year over year. Use the charts on this page to explore Vir Biotechnology's total liabilities history and peer comparisons.

Vir Biotechnology's total liabilities decreased from $250M to $230M — a 5.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vir Biotechnology reported $230M in total liabilities as of June 2026. That compares with $250M in the prior-year period — down 5.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $230M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vir Biotechnology, and consider following VIR for alerts when major investors trade the stock.

Vir Biotechnology is classified in the Healthcare sector. On total liabilities, it currently shows $230M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VIR with unrelated industries.